Drug intelligence / Profile preview

CartiSafe-Forte

Development stage
Unknown
Lead developer
Jenburkt Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

CartiSafe-Forte is a fixed-dose combination nutritional supplement developed by Jenburkt Pharmaceuticals. It contains glucosamine sulphate, methylsulfonylmethane (MSM), elemental calcium (as calcium carbonate), and vitamin D3 (cholecalciferol). It is formulated to provide comprehensive support for joint health, cartilage repair, and bone strength, making it particularly useful for individuals with osteoarthritis, osteoporosis, or joint pain. Glucosamine and MSM work synergistically to repair cartilage and reduce joint inflammation, while calcium and vitamin D3 strengthen bone density and facilitate calcium absorption.

Brand names
CartiSafe-ForteCartisafe ForteCartisafe Forte MSM
Other names
Cartisafe-Fortecalcium + glucosamine + methylsulfonylmethane + vitamin D3calcium carbonate + cholecalciferol + glucosamine sulphate + methylsulfonylmethaneglucosamine + calcium + vitamin D3 + MSM
02

Targets

CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on CartiSafe-Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CartiSafe-Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call